tiprankstipranks
Trending News
More News >
Cognetivity Neurosciences (CGNSF)
OTHER OTC:CGNSF
US Market

Cognetivity Neurosciences (CGNSF) Ratios

Compare
22 Followers

Cognetivity Neurosciences Ratios

CGNSF's free cash flow for Q3 2023 was C$0.76. For the 2023 fiscal year, CGNSF's free cash flow was decreased by C$ and operating cash flow was C$-24.26. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
0.25 0.33 1.81 0.70-
Quick Ratio
0.25 0.33 1.81 0.70-
Cash Ratio
0.21 0.25 1.41 0.57-
Solvency Ratio
-0.58 -1.71 -1.99 -2.61-
Operating Cash Flow Ratio
-0.56 -0.58 -2.03 -1.84-
Short-Term Operating Cash Flow Coverage
-4.60 -2.48 -6.24 -6.05-
Net Current Asset Value
C$ -10.06MC$ -5.82MC$ 786.32KC$ -300.08K-
Leverage Ratios
Debt-to-Assets Ratio
0.46 0.65 0.17 0.41-
Debt-to-Equity Ratio
-0.13 -0.23 0.36 -1.17-
Debt-to-Capital Ratio
-0.15 -0.30 0.27 6.98-
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00-
Financial Leverage Ratio
-0.29 -0.35 2.12 -2.84-
Debt Service Coverage Ratio
-2.75 -9.62 -4.92 -7.11-
Interest Coverage Ratio
-6.22 -215.64 -29.88 -46.54-
Debt to Market Cap
1.44 0.03 <0.01 0.03-
Interest Debt Per Share
0.02 0.02 <0.01 <0.01-
Net Debt to EBITDA
0.15 <0.01 0.57 0.10-
Profitability Margins
Gross Profit Margin
45.70%0.00%0.00%0.00%-
EBIT Margin
-14120.71%0.00%0.00%0.00%-
EBITDA Margin
-14067.80%0.00%0.00%0.00%-
Operating Profit Margin
-14085.44%0.00%0.00%0.00%-
Pretax Profit Margin
-16386.72%0.00%0.00%0.00%-
Net Profit Margin
-16386.72%0.00%0.00%0.00%-
Continuous Operations Profit Margin
-16386.72%0.00%0.00%0.00%-
Net Income Per EBT
100.00%100.00%100.12%99.43%-
EBT Per EBIT
116.34%100.54%102.57%102.13%-
Return on Assets (ROA)
-262.74%-654.79%-105.49%-353.59%-
Return on Equity (ROE)
95.52%231.30%-223.44%1005.61%-
Return on Capital Employed (ROCE)
82.30%367.78%-217.59%990.29%-
Return on Invested Capital (ROIC)
98.71%578.85%-159.77%-5889.85%-
Return on Tangible Assets
-273.36%-683.89%-107.38%-353.59%-
Earnings Yield
-755.50%-33.90%-5.67%-29.00%-
Efficiency Ratios
Receivables Turnover
0.12 0.00 0.00 0.00-
Payables Turnover
0.01 0.03 0.02 0.01-
Inventory Turnover
0.00 0.00 0.00 0.00-
Fixed Asset Turnover
0.73 0.00 0.00 0.00-
Asset Turnover
0.02 0.00 0.00 0.00-
Working Capital Turnover Ratio
>-0.01 0.00 0.00 0.00-
Cash Conversion Cycle
-28.40K -12.68K -20.32K -24.71K-
Days of Sales Outstanding
2.98K 0.00 0.00 0.00-
Days of Inventory Outstanding
0.00 0.00 0.00 0.00-
Days of Payables Outstanding
31.38K 12.68K 20.32K 24.71K-
Operating Cycle
2.98K 0.00 0.00 0.00-
Cash Flow Ratios
Operating Cash Flow Per Share
-0.06 -0.04 -0.03 -0.04-
Free Cash Flow Per Share
-0.06 -0.05 -0.03 -0.04-
CapEx Per Share
<0.01 <0.01 <0.01 <0.01-
Free Cash Flow to Operating Cash Flow
1.01 1.03 1.03 1.01-
Dividend Paid and CapEx Coverage Ratio
-85.27 -32.14 -39.11 -85.08-
Capital Expenditure Coverage Ratio
-85.27 -32.14 -39.11 -85.08-
Operating Cash Flow Coverage Ratio
-4.60 -2.48 -6.24 -6.05-
Operating Cash Flow to Sales Ratio
-130.99 0.00 0.00 0.00-
Free Cash Flow Yield
-671.07%-8.56%-5.90%-20.60%-
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.13 -2.95 -17.65 -3.45-
Price-to-Sales (P/S) Ratio
19.75 0.00 0.00 0.00-
Price-to-Book (P/B) Ratio
-0.10 -6.82 39.44 -34.67-
Price-to-Free Cash Flow (P/FCF) Ratio
-0.15 -11.68 -16.94 -4.85-
Price-to-Operating Cash Flow Ratio
-0.17 -12.05 -17.37 -4.91-
Price-to-Earnings Growth (PEG) Ratio
>-0.01 >-0.01 0.41 0.08-
Price-to-Fair Value
-0.10 -6.82 39.44 -34.67-
Enterprise Value Multiple
<0.01 -2.96 -17.82 -3.41-
Enterprise Value
-57.53K 38.64M 32.99M 8.85M-
EV to EBITDA
<0.01 -2.96 -17.82 -3.41-
EV to Sales
-1.27 0.00 0.00 0.00-
EV to Free Cash Flow
<0.01 -11.66 -16.42 -4.71-
EV to Operating Cash Flow
<0.01 -12.02 -16.84 -4.77-
Tangible Book Value Per Share
-0.10 -0.08 0.01 >-0.01-
Shareholders’ Equity Per Share
-0.10 -0.08 0.01 >-0.01-
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 >-0.01 <0.01-
Revenue Per Share
<0.01 0.00 0.00 0.00-
Net Income Per Share
-0.08 -0.18 -0.03 -0.06-
Tax Burden
1.00 1.00 1.00 0.99-
Interest Burden
1.16 1.00 1.03 1.02-
Research & Development to Revenue
13.25 0.00 0.00 0.00-
SG&A to Revenue
111.07 0.00 0.00 0.00-
Stock-Based Compensation to Revenue
12.31 0.00 0.00 0.00-
Income Quality
0.80 0.24 1.02 0.70-
Currency in CAD